pembrolizumab,vibostolimab,favezelimab
merck
['mibc', 'pembro', 'nmibc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'kn057']
fantastic presentation by on kn057 trial! meaningful data on efficacy &amp; safety aiming to address a very important need in pts who decline or cannot undergo radical cystectomy #gu23 
Oncologist, Professor, clinical/translational research, Genitourinary Cancers, bladder, prostate, testis, Univ of Washington, Fred Hutch; views are mine